Tag: vaccine

FDA panel endorses Pfizer coronavirus vaccine When will the treatment be available to the public? Infectious disease expert Dr. Amesh Adalja provides insight. An advisory committee member said the Food and Drug Administration may decide on Pfizer’s coronavirus vaccine emergency use authorization application as early as Saturday. Dr. Paul Offit, who voted in favor of the

Fox News Flash top headlines for December 11 Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com. The U.S. Food and Drug Administration (FDA) is working toward quickly finalizing and issuing emergency approval for Pfizer and BioNTech’s coronavirus vaccine candidate, according to top FDA officials. “Following yesterday’s positive advisory committee meeting outcome regarding the

India’s health ministry announced Tuesday that some COVID-19 vaccines are likely to receive licenses in the next few weeks and outlined an initial plan to immunize 300 million people. Health officials said three vaccine companies have applied for early approval for emergency use in India: Serum Institute of India, which has been licensed to manufacture

Documents released by U.S. regulators Tuesday confirmed that Pfizer’s vaccine was strongly protective against COVID-19 and appeared safe—offering the world’s first detailed look at the evidence behind the shots. The positive review from the Food and Drug Administration sets the stage for a decision allowing the vaccine’s initial use within days. FDA regulators posted their

Fiji’s national vaccine program against pneumonia, a serious lung condition, and rotavirus, a common disease which causes severe diarrhoea and vomiting, has reduced illness and death, new research shows. The University of Melbourne-led research team, which worked with the Fiji Ministry of Health and Medical Services, says the results underline the importance of vaccines and

Evidence suggesting an initial half dose of the vaccine being developed by drugs firm AstraZeneca and the University of Oxford is more effective than a full dose is counterintuitive, and even took the researchers by surprise. Why would less be better than more when it comes to triggering an immune response? Andrew Pollard, the director

G20 leaders will pledge to “spare no effort” in ensuring the equitable distribution of coronavirus vaccines worldwide and reaffirm support for debt-laden poor countries, according to a draft communique seen by AFP Sunday. The leaders also struck a unified tone on supporting “multilateral” trade as well as the global fight against climate change, but the

Pfizer will apply for FDA approval after announcing vaccine’s 95% percent effectiveness Fox News medical contributor Dr. Marc Siegel with Pfizer vaccine analysis and his take on when emergency authorization will likely take place. Pfizer and BioNTech announced on Friday that they were submitting an emergency use authorization request to the FDA for its coronavirus

Nearly a million people have taken an experimental coronavirus vaccine developed by Chinese company Sinopharm, the firm said, although it has not yet provided any clear clinical evidence of efficacy. China has been giving experimental COVID-19 vaccines to people including state employees, international students and essential workers heading abroad since July. Sinopharm’s chairman told media

Fox News Flash top headlines for November 19 Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com. Oxford University and AstraZeneca's coronavirus vaccine candidate was safe, boosted an immune response, and was better tolerated among older adults, according to phase 2 clinical trial data. Researchers recruited 560 participants, 240 of which were

Sen. Portman volunteers for Johnson & Johnson coronavirus vaccine trial Sen. Rob Portman, R-Ohio, calls recent vaccine developments ‘really exciting news,’ says ‘we need everybody to be willing to get vaccinated.’ In a series of tweets on Wednesday, Pfizer said it’s coronavirus vaccine candidate, which is being developed in conjunction with BioNTech, was found to

Now that two drug makers—Pfizer and Moderna—have reported highly effective results for their COVID-19 vaccines, it will be only a matter of time until they seek federal permission to release them for public consumption. If FDA approved, one of the many questions that could arise is whether Americans should be mandated to get a COVID-19

An experimental vaccine, designed to enlist the body’s own immune system to target cancer cells, has shown promise for treating and preventing cancer in mice. The vaccine was created to target a gene called KRAS that is involved in the development of many types of cancer, including lung, bowel and pancreatic cancer. Researchers from the

A COVID-19 vaccine candidate that underwent extensive preclinical testing at the University of Alabama at Birmingham this spring and summer shows potent preclinical immune responses—including several that distinguish it from other COVID-19 vaccine approaches—according to a preprint deposited in the BioRxiv repository this week. Partial preclinical results had been announced in July and August by

Emergency room doctor says COVID-19 and 1918 flu pandemic belong in the same conversation New medical study finds New York City coronavirus deaths in spring are comparable to 1918 flu pandemic; insight from Dr. Jeremy Faust, emergency physician at Brigham and Women’s Hospital. As health officials urge the public to get the flu shot in

In 2005, before most low- and middle-income countries started vaccinating children routinely for pneumococcal disease, it caused approximately 1.5 million deaths worldwide annually. About 700,000 to 1 million of these deaths were in children under five years. Pneumococcal disease occurs when Streptococcus pneumoniae invades a normally sterile area of the body, causing meningitis, pneumonia, septicaemia

A huge international study of a COVID-19 vaccine that aims to work with just one dose is getting underway as top U.S. health officials sought Wednesday to assure a skeptical Congress and public that they can trust any shots the government ultimately approves. Hopes are high that answers about at least one of several candidates

A new study conducted by IVI in collaboration with SK bioscience shows that single-dose and two-dose regimens of Vi-DT typhoid conjugate vaccine (TCV) are safe and immunogenic in children six to 23 months of age, a group with high rates of typhoid fever in resource-limited settings. The findings from this study, newly published online in

A vaccine for COVID-19 is seen by many—rightly or wrongly—as the finish line for the pandemic, the shot that will mark the resumption of our normal lives. Yet recent polls suggest that a significant fraction of Americans may opt not to get a vaccine when one becomes available, or are at least wary of getting

An international research network of physicians and scientists is launching a clinical trial to evaluate whether the vaccine for measles, mumps and rubella (MMR) can protect front-line health-care workers against infection from SARS-CoV-2, the virus that causes COVID-19. The trial aims to enroll up to 30,000 health-care workers globally. Washington University School of Medicine in